NXGL
Nexgel Inc
NASDAQ: NXGL · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$0.59
-1.63% today
Updated 2026-04-30
Market cap
$5.14M
P/E ratio
—
P/S ratio
0.45x
EPS (TTM)
$-0.38
Dividend yield
—
52W range
$1 – $3
Volume
0.4M
Nexgel Inc (NXGL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.32M | $-777000.00 | $-1.54M | $-1.81M | $-1.80M | $-2.75M | $-2.99M | $-3.24M | $-3.87M | $-1.31M |
| Capital expenditures | $0.00 | $7000.00 | $312000.00 | $312000.00 | $312000.00 | $269000.00 | $96000.00 | $696000.00 | $443000.00 | $68000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $12000.00 | $7000.00 | $206000.00 | $4000.00 | $232000.00 | $285000.00 | $298000.00 | $217000.00 | $367000.00 | $654000.00 |
| Free cash flow | $-1.32M | $-784000.00 | $-1.86M | $-2.13M | $-2.11M | $-3.02M | $-3.09M | $-3.93M | $-4.31M | $-1.38M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — |